This product is a combination of two antihypertensive drugs: a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker), amlodipine besilate, and an angiotensin II receptor blocker, olmesartan medoxomil. The amlodipine component inhibits the transmembrane influx of calcium..